Softwr

Healthcare · head to head

Therapixel vs Updox

Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-
Updox logo

Updox

Healthcare

Healthcare communications platform for eFax, telehealth and patient reminders

From
On request
Rated
-

The short version

  • Each has a real cost: Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.; Updox no specific dollar amounts listed on pricing page
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Therapixel and Updox actually diverge.

Attributes where Therapixel and Updox differ
AttributeTherapixelUpdox

Identical on both: starting price (On request), pricing model (quote), free tier (No), platforms (Web), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

Only in Updox

Nothing recorded that Therapixel does not also cover.

What people use each for

The jobs each tool is most often brought in to do.

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot Updox
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot Updox
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot Updox
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot Updox

Updox

  • Healthcare communication and patient engagementnot Therapixel
  • Medical practice fax, telehealth, and SMS messagingnot Therapixel
  • Charge capture and medical billing workflowsnot Therapixel
  • Multi-location healthcare systemsnot Therapixel

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

Updox

  • No specific dollar amounts listed on pricing page
  • Actual costs require contacting sales team or scheduling a demo
  • Standard and Enterprise tier limits shown but no pricing transparency

Pricing, plan by plan

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

Updox

On request

No published plan breakdown. See the Updox review.

Which should you pick?

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.

Choose Updox if

Nothing in the data separates Updox from Therapixel on the points above - pick on price and on how each one feels to use.

Questions people ask

Is Therapixel or Updox better?
Neither clearly leads. Therapixel starts at On request and Updox at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Therapixel or Updox?
Therapixel starts at On request and Updox at On request.
Does Therapixel or Updox run on more platforms?
Both run on Web, so platform support will not decide this one for you.
What is Therapixel best used for?
Therapixel is most often used for a european breast screening programme running mandatory double reading that wants to evaluate ai as a concurrent or second reader within what national guidance permits, an american breast centre that has moved to tomosynthesis and needs reading support on dbt specifically, which therapixel holds a clearance for, a screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own threshold, a radiology group evaluating multiple mammography ai vendors head to head on their own historic case set before committing. Of those, a european breast screening programme running mandatory double reading that wants to evaluate ai as a concurrent or second reader within what national guidance permits and an american breast centre that has moved to tomosynthesis and needs reading support on dbt specifically, which therapixel holds a clearance for are not what Updox is typically brought in for.
What can Therapixel do that Updox cannot?
Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report.

Answered from the vendors’ own pages

Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

Updox: How much does Updox cost?

Updox pricing is not published on the pricing page. The vendor offers customizable packages and directs inquiries to schedule a demo or contact the sales team for personalized pricing based on practice size and tool requirements.

Source
Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

Updox: What is Updox's pricing model?

Updox uses a usage-based pricing model with customizable packages. Costs are tailored based on the tools selected (fax pages, telehealth sessions, patient reminders, text messages, broadcast messages) and can scale with practice benchmark data.

Source
Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

Updox: What limits are included in Updox's Standard tier?

Updox Standard tier includes up to 1,000 fax pages, 75 telehealth sessions, reminders for 500 appointments, 500 text messages, and 500 broadcast messages monthly, with higher limits available in Enterprise tier.

Source
Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

Share

Related pages

Other head to heads